Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Salmeterol/Fluticasone Easyhaler vs Seretide Diskus in Healthy Subjects
NCT03238482Phase 1Completed
- Sponsor
- Orion Corporation
- Start
- Aug 2017
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of salmeterol + fluticasone in asthma (4 arms), sponsored by Orion Corporation. Primary endpoints: Peak Plasma Concentration of Salmeterol, Peak Plasma Concentration of Fluticasone Propionate and 3 more. Started Aug 2017; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03238482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238482.